We first compared HER2 expression levels across different carcinoma cell lines and confirmed that SGC7901 cells express a low level of HER2 compared to the HER2-negative MDA-MB-231 cells and the HER2-positive SK-BR-3 cells (Supplementary Figure S1). The gene discussed is ERBB2; the disease is carcinoma.